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“The first thing you have to know is yourself. Someone who knows 
himself can step outside himself and watch his own reactions like an 
observer.”  
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This thesis describes the synthesis and structure activity relationship  (SAR) of 
oxazolopyridine and related analogues against Trypanosoma brucei, the causative agent of 
Human African Trypanosomiasis, a neglected, fatal parasitic disease that is a major cause of 
death and disability affecting many sub-Saharan African countries.   
Collaborators at Monash Institute of Pharmaceutical Science (MIPs), and ESKITIS institute 
found eight compounds as potential candidates via high throughput screening (HTS) of a 
large library of compounds against the disease. Amongst the compounds screened, an 
oxazolo[4,5-b]pyridine compound was of particular interest. In collaboration with MIPS, this 
work aimed to modify certain regions of the lead compounds and to develop a SAR against T. 
brucei, aiming for the synthesis of better analogues of the lead compound, as discussed in 
Chapter 2 and Chapter 3. A number of compounds have been made through modification 
around the central phenyl ring and the heterocyclic oxazolopyridine core. Modification at the 
central phenyl ring revealed the intolerance of that position for substitution, while the best 
compounds remained either the lead compound itself or its analogues, with the chlorine being 
replaced by either a hydrogen or substituting the 2-furyl amide for its 3-furyl counterpart. 
Modification of the heterocyclic core has resulted in a number of active compounds. We 
suggested that the modification and substitutions on oxazolopyridine core is more favourable 
for better activity.  
In addition to the anti-trypanosomal activities, these compounds are similar to heterocyclic 
amine derivatives found in cooked meat and fish, which has the potential to cause cancer. 
This has prompted us to investigate the potential for DNA damage activity of these 

















DMF                 Dimethyl formamide  
DMAP Dimethylaminopyridine 




High throughput screening 
Mass spectrometry 
Nuclear Magnetic resonance 
PPA                     Polyphosphoric acid 
SAR                     Structure activity relationship 
EDCI                                  1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
T. Brucei             Trypanosoma brucei 










As part of this thesis, the author contributed to the synthesis and structural characterisation to 
library of compounds. These compounds were synthesised by the author and were sent to 
collaborators in Professor Jonathan Baell’s group (Monash University) to add to a larger 
library where the screening against T. brucei were conducted at the ESKITIS institute at 
Griffith University. These compounds and their hetrocyclic-amine precursors were also 
assessed for DNA damage activity, by Associate Professor Nuri Guven (Pharmacy School at 
UTAS).  
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